Editor’s summary Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES AND NOTES Information & Authors Metrics & Citations View Options References Figures Tables Media Share Editor’s summary Gliomas with mutations in isocitrate dehydrogenase 1 or 2 (IDH1/2) are poorly understood mainly because of a lack of mutant IDH inhibitor (mIDHi)–responsive glioma models. To address this, Shi et al.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile